Acute kidney injury (AKI) is a common complication in patients with end-stage liver disease and advanced cirrhosis regardless of the underlying cause. Hepatorenal syndrome (HRS), a functional form of kidney failure, is one of the many possible causes of AKI.
Diagnostic Criteria of Hepatorenal Syndrome (HRS)
Major criteria
-
Low glomerular filtration rate, as indicated by serum creatinine greater than 1.5 mg/dl or 24-hour creatinine clearance lower than 40 ml/minute
-
Absence of shock, ongoing bacterial infection, fluid losses and current treatment with nephrotoxic drugs
-
No sustained improvement in renal function (decrease in serum creatinine to 1.5 mg/dl or less or increase in creatinine clearance to 40 ml/minute or more) following diuretic withdrawal and expansion of plasma volume with 1.5 l of a plasma expander
-
Proteinuria lower than 500 mg/day and no ultrasonographic evidence of obstructive uropathy or parenchymal renal disease
Additional criteria
-
Urine volume lower than 500 ml/day
-
Urine sodium lower than 10 mEq/l
-
Urine osmolality greater than plasma osmolality
-
Urine red blood cells less than 50 per high-power field
-
Serum sodium concentration lower than 130 mEq/l
All major criteria must be present for the diagnosis of hepatorenal syndrome. Additional criteria are not necessary for the diagnosis, but provide supportive evidence.
Clinical types of hepatorenal syndrome
- Type I: Rapid and progressive impairment of renal function as defined by a doubling of the initial serum creatinine to a level higher than 2.5 mg/dl or a 50% reduction of the initial 24-hour creatinina clearance to a level lower than 20 ml/minute in less than 2 weeks
- Type II: Impairment in renal function (serum creatinine 41.5 mg/dl) that does not meet the criteria of type I
References:
-
Gines P. Diagnosis and treatment of hepatorenal syndrome. Baillieres Best Pract Res Clin Gastroenterol. 2000 Dec;14(6):945-57. [Medline]
Created: Apr 12, 2007